Skip to main content
. 2016 May 17;7(27):41703–41714. doi: 10.18632/oncotarget.9406

Figure 3. ROC curves comparing the diagnostic performance of the combination model with individual AIB1, EIF5A2, or NMP22 in the training and independent validation sets.

Figure 3

Comparisons of the diagnostic performance by the model and individual AIB1, EIF5A2 or NMP22 in the training cohort A. and independent validation set B..